Flagship Harbor Advisors, LLC Compass Therapeutics, Inc. Transaction History

Flagship Harbor Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$2.64 - $3.48 $1,320 - $1,740	-500 Reduced 4.35%	11,000 $34,000
Q4 2022 Jan 13, 2023	SELL	$2.55 - $5.41 $6,375 - $13,525	-2,500 Reduced 17.86%	11,500 $0
Q2 2022 Jul 13, 2022	BUY	$1.43 - $3.1 $20,020 - $43,400	14,000 New	14,000 $37,000

92M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $161M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.